Barrick’s Canadian Exit Opens The Doors For US Redomiciliation
Barrick Gold Corp. (NYSE:GOLD), the world’s second-largest gold miner, is preparing to exit Canada completely by selling its final domestic asset—the Hemlo gold mine in Ontario. Surging gold prices triggered the company’s decision to optimize its portfolio, focusing on higher-margin operations. Located near Marathon, Ontario, Hemlo has been in continuous production for over 30 years, […]
World’s Largest Miner BHP Quietly Prepares For CEO Succession
The world’s largest miner, BHP Group (NYSE:BHP), is reportedly preparing for a leadership transition as CEO Mike Henry’s tenure approaches its expected conclusion. While no formal announcement has been made, company insiders suggested the board could initiate the succession process soon, with a potential handover in early 2026. According to information the company’s insiders shared […]
$5 Billion Bid From US Investor For ERG Opens Speculations For Kazakhstan’s Rare Earth Riches
American Businessman James Cameron has reportedly offered $5 billion to acquire Eurasian Resources Group (ERG), the world’s largest producer of high-carbon ferrochrome by chrome content. ERG has been headquartered in Luxembourg since its $4.5 billion privatization in 2013, and Kazakhstan’s government has a 40% stake in its global operations, which span 16 countries and four […]
Blackwater Founder Reaches a Security Deal With DR Congo
Erik Prince, a businessman and longtime supporter of President Donald Trump, has reportedly agreed to help the Democratic Republic of Congo (DRC) secure and tax its vast mineral wealth. According to Reuters, he reached the agreement before the M23 rebel group launched a major offensive in January 2025 that saw them seize key cities in […]
FDA Delays Full Approval Decision On Novavax’s COVID-19 Vaccine
In September 2024, the U.S. Food And Drug Administration (FDA) granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in individuals aged 12 and older. Novavax’s vaccine was included in the recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC) on June 27, 2024. Also […]
KKR Mulls To Buy Japan-Based Eye Care Company Topcon
KKR & Co Inc (NYSE:KKR) is close to acquiring Tokyo-based eye care company Topcon Corp (OTC:TOPCF) (OTC:TOPCY). According to Reuters, the private equity firm expects to sign the deal in the coming days. The price has not been disclosed yet. The Japan-based manufacturer of optical equipment for ophthalmology and surveying has an enterprise value of around […]
Philip Morris Considers Selling US Cigar Business As It Pushes Towards Smoke-Free Products: Bloomberg
Marlboro cigarette maker Philip Morris International Inc. (NYSE:PM) is reportedly exploring a potential sale of its U.S. cigar business. The company added the U.S. cigar business via its massive $16 billion acquisition deal with Swedish Match AB. The move accelerates Philip Morris’ transition toward smoke-free products. Benzinga has contacted Philip Morris for comment on the […]
UnitedHealthcare Offers Voluntary Buyouts, Possible Layoffs If Targets Not Met: CNBC
UnitedHealthcare, the insurance arm of UnitedHealth Group (NYSE:UNH), is reportedly offering some employees in its benefits operations unit a chance to take a buyout if they resign by March 3. In January, UnitedHealth announced that Tim Noel will be CEO of the UnitedHealthcare after the segment’s former chief executive was murdered in New York last month. […]
Why Is Walgreens Boots Alliance Stock Trading Higher On Tuesday?
As per a media report in December, Walgreens Boots Alliance Inc (NASDAQ:WBA) suggested the company is in talks to be acquired by Sycamore Partners. Walgreens’s market value has shrunk from over $100 billion a decade ago to around $8.4 billion, as per data from Benzinga Pro. Earlier on Tuesday, citing CNBC, the Bloomberg report noted […]
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
Johnson & Johnson (NYSE:JNJ) is reportedly considering selling its stroke care unit, Cerenovus, in a deal that could value the business at more than $1 billion. The move aligns with the company’s ongoing efforts to streamline its medical technology division following a series of acquisitions. The healthcare giant has engaged advisers to gauge interest from […]